Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-16,802
Closed -$133K 4308
2025
Q2
$133K Sell
16,802
-7,149
-30% -$53.9K ﹤0.01% 2278
2025
Q1
$185K Sell
23,951
-916
-4% -$8.01K ﹤0.01% 2046
2024
Q4
$255K Buy
24,867
+116
+0.5% +$1.08K ﹤0.01% 1886
2024
Q3
$229K Sell
24,751
-1,128
-4% -$9.27K ﹤0.01% 1969
2024
Q2
$212K Sell
25,879
-1,800
-7% -$17K ﹤0.01% 1975
2024
Q1
$334K Buy
27,679
+11,082
+67% +$122K ﹤0.01% 1738
2023
Q4
$183K Buy
16,597
+16,269
+4,960% +$157K ﹤0.01% 2056
2023
Q3
$3.23K Hold
328
﹤0.01% 3559
2023
Q2
$4.31K Hold
328
﹤0.01% 3515
2023
Q1
$3.58K Hold
328
﹤0.01% 3630
2022
Q4
$2.82K Buy
+328
New +$3.75K ﹤0.01% 3687

Other funds holding XPER

US Bancorp's XPER Position: Q3 2025 in Review

US Bancorp sold out of Xperi (XPER) in Q3 2025, closing a stake of 16,802 shares — an estimated $133K sold.

US Bancorp first reported a position in XPER in Q4 2022 and held it in 11 quarters. The position peaked at $334K in Q1 2024. 143 funds tracked by Wall St. Rank hold XPER as of Q3 2025.

  • US Bancorp reported no remaining Xperi position as of Q3 2025 after selling out during the quarter.
  • US Bancorp sold 16,802 Xperi shares in Q3 2025, an estimated $133K.
  • US Bancorp first reported a position in Xperi in Q4 2022 and held it in 11 quarters.
  • US Bancorp's Xperi position peaked at $334K in Q1 2024.
  • 143 funds tracked by Wall St. Rank held Xperi as of Q3 2025.

Based on US Bancorp's 13F filing for Q3 2025, filed 12 Nov 2025.